This is the top big-box retailer to own into year-end, according to Wolfe

Wolfe Research upgraded Target (TGT) to Outperform/Top pick with a $160 price target (vs. downside to ~$120), citing faster store transformation and improved execution. The firm expects EPS of ~$8.48 in 2026 (raised) and ~$9.52 in 2027, modeling a 17x multiple to support the upside. It also notes stronger customer trends, with new customer mix accelerating to 4.1% over the last four weeks (vs. -8.0% over the prior 52-week trend), while Q1 same-store sales grew 5.6%.

Analysis

This is less a pure fundamentals upgrade than a sentiment reset on execution credibility. The market is effectively being asked to re-rate Target from a low-confidence self-help story to a quasi-share-gain compounder; that only works if store reset productivity shows up in traffic and, more importantly, in gross margin recovery within the next 2-3 quarters. The first beneficiaries are likely adjacent vendors and private-label suppliers tied to apparel, home, and beauty assortments, while the competitive pressure falls on department stores and mall-based names that rely on the same discretionary basket.

The key second-order effect is mix: if Target is pulling back lapsed customers, it can gain share without needing broad consumer strength, which would be more durable than a macro-led comp beat. But because reinvestment is suppressing near-term flow-through, the stock can still disappoint even with decent top-line numbers if investors do not see operating leverage by back half of this year. That makes this a multiple story first and an EPS story second.

Catalyst risk is concentrated around the next two earnings prints: if comps hold above the low-single-digit range and inventories stay clean, estimate revisions should continue and the stock can earn a higher multiple; if traffic normalizes after refund season or margin mix remains weak, the upgrade becomes a fade. The contrarian miss is that investors may be extrapolating a few weeks of better store conditions into a durable brand turn, when in retail the more important test is repeat purchase after the easy comparisons roll off. Downside is not extreme if the turnaround is real, but it becomes very tradable if the stock outruns the revision cycle before evidence catches up.

Key Decisions for Investors

• Tactical long TGT on a pullback over the next 1-2 sessions; target a 10-15% move if second-quarter comps and margin commentary confirm the revision cycle. Stop if the stock closes back below the post-upgrade breakout level or if management guidance fails to tighten.
• Pair trade: long TGT / short XRT for a 1-3 month catalyst window. This isolates idiosyncratic execution from broader retail beta and should work if revisions cluster around Target rather than the sector.
• If entering options, consider a 3-6 month TGT call spread rather than outright calls to monetize expected multiple expansion while capping premium bleed if the market waits for proof. Best use case is ahead of the next earnings release.
• Watch for a short signal if same-store sales fall back toward consensus while gross margin remains flat; that would argue the current re-rating is ahead of fundamentals and likely compresses back toward the low-teens multiple.
• Avoid chasing WMT as the hedge here; its food/necessity mix makes it a poor direct short. If you want a loser leg, use a higher-beta discretionary retail basket or XRT instead.